Relative Bioavailability of Coenzyme Q10 in Emulsion and Liposome Formulations
![]() ![]() |
Choi, Chee-Ho
(College of Pharmacy, Chungbuk National University)
Kim, Si-Hun (College of Pharmacy, Chungbuk National University) Shanmugam, Srinivasan (College of Pharmacy, Yeungnam University) Baskaran, Rengarajan (College of Pharmacy, Yeungnam University) Park, Jeong-Sook (College of Pharmacy, Chungbuk National University) Yong, Chul-Soon (College of Pharmacy, Yeungnam University) Choi, Han-Gon (College of Pharmacy, Yeungnam University) Yoo, Bong-Kyu (College of Pharmacy, Yeungnam University) Han, Kun (College of Pharmacy, Chungbuk National University) |
1 | Levy, G., Kaufmann, P., Buchsbaum, R., Montes, J., Barsdorf, A., Arbing, R., Battista, V., Zhou, X., Mitsumoto, H., Levin, B. and Thompson, J. (2006). A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 66, 660-663. DOI |
2 | Liu, Z. X. and Artmann, C. (2009). Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern. Ther. Health Med. 15, 42-46. |
3 | Makabi-Panzu, B., Sprott, G. D. and Patel, G. B. (1998). Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein. Vaccine 16, 1504-1510. DOI |
4 | Bhagavan, H. N. and Chopra, R. K. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research 40, 445-453. DOI |
5 | Bonakdar, R. A. and Guarneri, E. (2005). Coenzyme Q10. Am. Fam. Physician 72, 1065-1070. |
6 | Bonuccelli, U. and Del Dotto, P. (2006). New pharmacologic horizons in the treatment of Parkinson disease. Neurology 67, S30-38. DOI |
7 | Buettner, C., Phillips, R., Davis, R., Gardiner, P. and Mittleman, M. (2007). Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am. J. Cardiol. 99, 661-666. DOI |
8 | Conklin, K. (2005). Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr. Cancer Ther. 4, 110-130. DOI |
9 | Crane, F. (2001). Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20, 591-598. DOI |
10 | Singh, U., Devaraj, S. and Jialal, I. (2007). Coenzyme Q10 supplementation and heart failure. Nutr. Rev. 65, 286-293. DOI |
11 | Smith, K., Matson, S., Matson, W., Cormier, K., Del Signore, S., Hagerty, S., Stack, E., Ryu, H. and Ferrante, R. (2006). Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochim. Biophys. Acta 1762, 616-626. DOI ScienceOn |
12 | Sun, I., Sun, E., Crane, F., Morro, D., Lindgren, A. and Low, H. (1992). Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 89, 11126-11130. DOI |
13 | Tomono, Y., Hasegawa, J., Seki, T., Motegi, K. and Morishita, N. (1986). Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 536-541. |
14 | Hyun, D., Emerson, S., Jo, D., Mattson, M. and De Cabo, R. (2006). Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc. Natl. Acad. Sci. USA 103, 19908-19912. DOI |
15 | Janson, M. (2006). Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging. Clin. Interv. Aging 1. 261-265. DOI |
16 | Littarru, G. and Tiano, L. (2005). Clinical aspects of coenzyme Q10: an update. Curr. Opin. Clin. Nutr. Metab. Care 8, 641-646. DOI |
17 | Kurowska, E. M., Dresser, G., Deutsch, L., Bassoo, E. and Freeman, D. J. (2003). Relative bioavailability and antioxidant potential of two coenzyme q10 preparations. Ann. Nutr. Metab. 47, 16-21. DOI |
18 | Laaksonen, R., Ojala, J., Tikkanen, M. and Himberg, J. (1994). Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors. Eur. J. Clin. Pharmacol. 46, 313-317. |
19 | Ratnam, D., Ankola, D., Bhardwaj, V., Sahana, D. and Kumar, M. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Rel. 113, 189- 207. DOI |
20 | Roffe, L., Schmidt, K. and Ernst, E. (2004). Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. J. Clin. Oncol. 22, 4418-4424. DOI |
21 | Sassi, S., Genova, M. and Lenaz, G. (1994). Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Int. J. Clin. Lab. Res. 24, 171-176. DOI |
22 | Schulz, C., Obermuller-Jevic, U. C., Hasselwander, O., Bernhardt, J. and Biesalski, H. K. (2006). Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10). Int. J. Food Sci. Nutr. 57, 546-555. DOI |
23 | Shults, C. and Haas, R. (2005). Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 25, 117-126. DOI |
24 | Ferrante, K., Shefner, J., Zhang, H., Betensky, R., O'Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M., Traynor, B., Newhall, K., Donofrio, P., Caress, J., Ashburn, C., Freiberg, B., O'Neill, C., Paladenech, C., Walker, T., Pestronk, A., Abrams, B., Florence, J., Renna, R., Schierbecker, J., Malkus, B. and Cudkowicz, M. (2005). Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 65, 1834-1836. DOI |
25 | Tran, M. T., Mitchell, T. M., Kennedy, D. T. and Giles, J. T. (2001). Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy 21, 797-806. DOI |
26 | Yang, H., Lin, S., Huang, S. and Chou, H. (2005). Acute administration of red yeast rice (Monascus purpureus) depletes tissue coenzyme Q(10) levels in ICR mice. Br. J. Nutr. 93, 131-135. DOI |
27 | Young, J., Florkowski, C., Molyneux, S., McEwan, R., Frampton, C., George, P. and Scott, R. (2007). Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am. J. Cardiol. 100, 1400-1403. DOI |
28 | Greenberg, S. and Frishman, W. H. (1990). Co-enzyme Q10: a new drug for cardiovascular disease. J. Clin. Pharmacol. 30, 596-608. DOI |
29 | Hodgson, J., Watts, G., Playford, D., Burke, V. and Croft, K. (2002). Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur. J. Clin. Nutr. 56, 1137-1142. DOI |
30 | Hsu, C. H., Cui, Z., Mumper, R. J. and Jay, M. (2003). Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS Pharm. Sci. Tech. 4, E32. DOI |
31 | Leonhauser, S., Lebold, K., Krisch, K., Standinger, H., Gale, F., Page, A. Jr. and Folkers, K. (1962). On the presence and significance of coenzyme Q in microsomes. Arch. Biochem. Biophys. 96, 580-586. DOI |
32 | Zmitek, J., Smidovnik, A., Fir, M., Prosek, M., Zmitek, K., Walczak, J. and Pravst, I. (2008). Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann. Nutr. Metab. 52, 281-287. DOI ScienceOn |
33 | Shults, C., Flint Beal, M., Song, D. and Fontaine, D. (2004). Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol. 188, 491-494. DOI |
![]() |